CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 60 enrolled
Drug / intervention
Ketorolac +1 moredrug
Likely dose
Ketorolac 30 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00868348
NCT00868348Phase 4Completed
CompareCT.gov

Local Infiltration Analgesia for Total Knee Arthroplasty: Should Ketorolac be Added

University of Aarhus·interventional·Posted Mar 25, 2009·Updated Mar 10, 2014

In Brief

A Phase 4 clinical trial evaluating Ketorolac and Saline for Postoperative Pain. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The purpose of this study is to determine wether ketorolac is effective in the treatment of postoperative pain after total knee arthroplasty

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesDenmark
Collaborators--

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 25, 2009
Enrollment StartMay 1, 2009
Primary CompletionJun 1, 2011
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 17.3 years ago

Interventions

Ketorolacdrug

30 mg (1 ml) infiltration combined with Intraarticular bolus injection of 120 mg (4 ml) ketorolac

Salinedrug

1 ml infiltration 4 ml intraarticular bolus injection of placebo